Investigational Site Number 528003

Maastricht 6229 HX

0 studies enrolling now · 2 studies all time

What they study most

Arrhythmia Prophylaxis, Hematopoietic Neoplasm, Ventricular Arrhythmia

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death — Completed